A Phase I Clinical and Pharmacokinetic Evaluation of LY293111 in Patients With Solid Tumors (Protocol H6H-MC-JEAI).
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Etalocib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.